<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font21 { font-size : 21; } .font26 { font-size : 26; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; }</style>
 <body>
  <p>
   <span class="font30">treatment </span>
   <span class="font26">patients </span>
   <span class="font21">MDR-TB </span>
   <span class="font16">(%) </span>
   <span class="font14">[]. </span>
   <span class="font14">(.) </span>
   <span class="font14">[], </span>
   <span class="font13">HIV </span>
   <span class="font13">HIV-infected </span>
   <span class="font13">high </span>
   <span class="font13">{border-style </span>
   <span class="font13">outcomes </span>
   <span class="font13">ART </span>
   <span class="font13">clinic </span>
   <span class="font13">px;} </span>
   <span class="font13">second-line </span>
   <span class="font12">#ffffff;} </span>
   <span class="font12">line </span>
   <span class="font12">patient </span>
   <span class="font12">started </span>
   <span class="font12">resistance </span>
   <span class="font12">tuberculosis </span>
   <span class="font12">Tuberculosis </span>
   <span class="font12">cohort </span>
   <span class="font12">drugs </span>
   <span class="font12">Mumbai, </span>
   <span class="font12">clinical </span>
   <span class="font12">co-infected </span>
   <span class="font12">treatment, </span>
   <span class="font12">treatment. </span>
   <span class="font12">Patients </span>
   <span class="font12">Treatment </span>
   <span class="font12">adverse </span>
   <span class="font12">study </span>
   <span class="font12">mortality </span>
   <span class="font11">India </span>
   <span class="font11">early </span>
   <span class="font11">months </span>
   <span class="font11">second </span>
   <span class="font11">India. </span>
   <span class="font11">MSF </span>
   <span class="font11">Mumbai </span>
   <span class="font11">culture </span>
   <span class="font11">initiation </span>
   <span class="font11">private </span>
   <span class="font11">program </span>
   <span class="font11">rates </span>
   <span class="font11">regimen </span>
   <span class="font11">results </span>
   <span class="font11">DOT </span>
   <span class="font11">Dis </span>
   <span class="font11">Health </span>
   <span class="font11">Med </span>
   <span class="font11">care </span>
   <span class="font11">drug </span>
   <span class="font11">public </span>
   <span class="font11">time </span>
   <span class="font11">DST </span>
   <span class="font11">antiretroviral </span>
   <span class="font11">diagnosed </span>
   <span class="font11">diagnosis </span>
   <span class="font11">management </span>
   <span class="font11">multidrug-resistant </span>
   <span class="font11">patients. </span>
   <span class="font11">pulmonary </span>
   <span class="font11">px; </span>
   <span class="font11">sector </span>
   <span class="font11">{font-family </span>
   <span class="font11">Lung </span>
   <span class="font11">Organization </span>
   <span class="font11">Table </span>
   <span class="font11">Tuberc </span>
   <span class="font11">World </span>
   <span class="font11">based </span>
   <span class="font11">confirmed </span>
   <span class="font11">control </span>
   <span class="font11">events </span>
   <span class="font11">follow-up </span>
   <span class="font11">font-size </span>
   <span class="font11">infection </span>
   <span class="font11">patients, </span>
   <span class="font11">previous </span>
   <span class="font11">therapy </span>
   <span class="font11">using </span>
   <span class="font11">(WHO) </span>
   <span class="font11">Figure </span>
   <span class="font11">Indian </span>
   <span class="font11">Int </span>
   <span class="font11">Médecins </span>
   <span class="font11">National </span>
   <span class="font11">Research </span>
   <span class="font11">Sans </span>
   <span class="font11">available </span>
   <span class="font11">burden </span>
   <span class="font11">challenges </span>
   <span class="font11">characteristics </span>
   <span class="font11">collab: </span>
   <span class="font11">community </span>
   <span class="font11">double; </span>
   <span class="font11">drug-resistant </span>
   <span class="font11">health </span>
   <span class="font11">history </span>
   <span class="font11">including </span>
   <span class="font11">network </span>
   <span class="font11">particularly </span>
   <span class="font11">psychosocial </span>
   <span class="font11">shown </span>
   <span class="font11">sputum </span>
   <span class="font11">standardized </span>
   <span class="font11">suspected </span>
   <span class="font11">used </span>
   <span class="font10">Adverse </span>
   <span class="font10">Control </span>
   <span class="font10">Drug </span>
   <span class="font10">Geneva </span>
   <span class="font10">HIV/MDR-TB </span>
   <span class="font10">Overall, </span>
   <span class="font10">access </span>
   <span class="font10">ambulatory </span>
   <span class="font10">bacteriologically </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">cases </span>
   <span class="font10">data </span>
   <span class="font10">default </span>
   <span class="font10">died, </span>
   <span class="font10">drugs. </span>
   <span class="font10">failed </span>
   <span class="font10">first-line </span>
   <span class="font10">included </span>
   <span class="font10">laboratory </span>
   <span class="font10">large </span>
   <span class="font10">outcome </span>
   <span class="font10">received </span>
   <span class="font10">recent </span>
   <span class="font10">referred </span>
   <span class="font10">report </span>
   <span class="font10">resistant </span>
   <span class="font10">settings </span>
   <span class="font10">seven </span>
   <span class="font10">smear </span>
   <span class="font10">solid; </span>
   <span class="font10">support </span>
   <span class="font10">survival </span>
   <span class="font10">team </span>
   <span class="font10">trained </span>
   <span class="font10">treating </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">ART, </span>
   <span class="font10">CD-count </span>
   <span class="font10">Despite </span>
   <span class="font10">Disease </span>
   <span class="font10">Frontières, </span>
   <span class="font10">However, </span>
   <span class="font10">India: </span>
   <span class="font10">Infectious </span>
   <span class="font10">MDR-TB, </span>
   <span class="font10">Outcomes </span>
   <span class="font10">Xpert </span>
   <span class="font10">achieved </span>
   <span class="font10">anti-TB </span>
   <span class="font10">bold </span>
   <span class="font10">collected </span>
   <span class="font10">conversion </span>
   <span class="font10">courier; </span>
   <span class="font10">death </span>
   <span class="font10">defined </span>
   <span class="font10">designed </span>
   <span class="font10">despite </span>
   <span class="font10">drugs, </span>
   <span class="font10">em; </span>
   <span class="font10">end </span>
   <span class="font10">enrolled </span>
   <span class="font10">entered </span>
   <span class="font10">global </span>
   <span class="font10">initiated </span>
   <span class="font10">injectable </span>
   <span class="font10">intensive </span>
   <span class="font10">likely </span>
   <span class="font10">measures </span>
   <span class="font10">median </span>
   <span class="font10">monthly </span>
   <span class="font10">need </span>
   <span class="font10">new </span>
   <span class="font10">positive </span>
   <span class="font10">pre-treatment </span>
   <span class="font10">pt;} </span>
   <span class="font10">rapid </span>
   <span class="font10">recorded </span>
   <span class="font10">related </span>
   <span class="font10">relatively </span>
   <span class="font10">reported </span>
   <span class="font10">routinely </span>
   <span class="font10">setting </span>
   <span class="font10">starting </span>
  </p>
 </body>
</html>
